Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) Stock Ticker

NASDAQ: GRI · Healthcare · Biotechnology
$2.05-1.91%
USD · as of 2026-09-27 · market cap $184,156
Open GRI in TickrDownload for iPhone

GRI right now

Trades at 0x earnings — about half the industry's multiple.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full GRI picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on GRI
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About GRI Bio, Inc.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

GRI stock facts

Ticker symbolGRI
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$184,156
CEOW. Marc Hertz
Employees4
HeadquartersLa Jolla, CA, US
IPO date2021-02-10
Websitewww.gribio.com

What you can see for GRI on Tickr

Live GRI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GRI report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for GRI Bio, Inc.?

The ticker symbol for GRI Bio, Inc. is GRI, listed on the NASDAQ.

What is GRI?

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung…

HomeExploreMarketLists
All pages